Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
R3918-AMD-2501
Phase 1 other active
Quick answer
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants for Geographic Atrophy is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Geographic Atrophy
- Phase
- Phase 1
- Modality
- other
- Status
- active